There is a paucity of NR0B2 expression from human cancer specimens, and so far, only two reports showed NR0B2 downregulation in 10 cases of liver cancers (HCC) (14) and 24 cases of renal cancers (RCC) (10). This evidence concerns the gene NR0B2 and hepatocellular carcinoma.